ClinicalTrials.Veeva

Menu

The Effect Of Medical Nutritional Therapy On Patients With Sarcopenic Obesity Receiving Peritoneal Dialysis Treatment

A

Atlas University

Status

Completed

Conditions

Sarcopenic Obesity
Peritoneal Dialysis Complication

Treatments

Other: medical nutrition therapy in kidney diseases

Study type

Interventional

Funder types

Other

Identifiers

NCT05797181
ABDemirbasPD

Details and patient eligibility

About

In this study, it was aimed to evaluate the effectiveness of medical nutrition therapy to be applied to patients with sarcopenic obesity receiving peritoneal dialysis treatment by measuring anthropometric measurements and blood parameters.

Full description

Efficacy of medical nutrition therapy in patients with sarcopenic obesity receiving peritoneal dialysis treatment, general information form after patients filled in the voluntary consent form, SARC-F questionnaire as sarcopenia screening test, International Physical Activity Questionnaire (IPAQ), muscle mass, muscle strength, physical performance, BIA measurement, anthropometric measurements, laboratory findings and three-day food consumption records will be evaluated.

Enrollment

15 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Volunteering to participate in research
  • Be between the ages of 18-70
  • To receive peritoneal dialysis treatment and to come to the hospital regularly once a month for treatment

Exclusion criteria

  • Presence of any other disease that causes muscle wasting
  • Patients using any supplement or enteral product in their diet

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

15 participants in 1 patient group

Dietary and Behavioral Change Group
Experimental group
Description:
The experimental group will be required to adhere to a diet consisting of a 10-15% reduction in carbohydrate and a 1.2-1.4 g/kg body weight/day intake of protein. The participants will receive 4 times face-to-face meetings (on the first day and on week 1,5 and 9). Each face-to-face interview will last approximately 30 minutes. During the interview researcher will help the participants to determine their nutritional behaviors, plan and implement the diet.
Treatment:
Other: medical nutrition therapy in kidney diseases

Trial contacts and locations

1

Loading...

Central trial contact

Ayşe Betül Demirbaş

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems